(2E)-3-(3-bromophenyl)-1-(4-methylphenyl)prop-2-en-1-one, 95.0%, 2g

3,3-Dimethyl-piperazin-2-one, 95.0%, 250mg

5-Hydroxy-4-methylpicolinonitrile, 97.0%, 100mg

N-BOC-3-BROMO-6-NITROINDOLE, 97.0%, 500mg

Ether monoéthylique de propylèneglycol, min 99%, pour la synthèse, 5L, emballage plastique.

2-Fluoro-5-(trifluoromethoxy)aniline, 95.0%, 5g

4-Fluoro-3-nitrobenzaldehyde>95.0%(GC)5g

4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97%, 1g

METHYL 4-METHYL-1-NAPHTHOATE, 95.0%, 250mg

4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one, 95+%, 250mg

1-Benzyl-2-phenyl-1H-benzoimidazole, 97.0%, 250mg

Benzo[d][1,3]dioxol-2-one, 95.0%, 1g

(2R,3R)-Butane-2,3-diylbis(diphenylphosphine), 97%, 5g